Category: Approval/Launch Region: Europe · United Kingdom Company: Roche Diabetes Care Ltd

EMAs committee recommends conditional marketing approval for Roches bispecific antibody mosunetuzumab to treat r/r follicular lymphoma

EMAs committee recommends conditional marketing approval for Roches bispecific antibody mosunetuzumab to treat r/r follicular lymphoma
Roche announced that the European Medicines Agency

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!